Additionally, kinase-independent effects of CDK8 have also been previously described in melanoma cells and hematologic malignancies [16, 52, 53], while the effect of CDK8 on ER+ breast cancer progression is kinase dependent [17]. This evidence concerns the gene CDK8 and melanoma.